Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient™. 

Rehabtronics, a leading innovator in neurostimulation technologies, is pleased to announce that it has been selected by the Praxis Spinal Cord Institute to conduct a usability and validation study...

Evogene Ltd. a leading computational biology company targeting to revolutionize life-science product development across multiple market segments, and Verb Biotics LLC. A microbiome health ingredient company...

Viscient Biosciences ("Viscient") announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk...

CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced the evolution of its loyalty program to include two membership tiers: ExtraCare® and ExtraCare Plus™.

Octapharma USA has announced Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) is now available.